TWI430814B - 含有非聚集鋅奈米顆粒之口腔組成物 - Google Patents
含有非聚集鋅奈米顆粒之口腔組成物 Download PDFInfo
- Publication number
- TWI430814B TWI430814B TW095126460A TW95126460A TWI430814B TW I430814 B TWI430814 B TW I430814B TW 095126460 A TW095126460 A TW 095126460A TW 95126460 A TW95126460 A TW 95126460A TW I430814 B TWI430814 B TW I430814B
- Authority
- TW
- Taiwan
- Prior art keywords
- zinc
- oral
- film
- oral composition
- nanoparticle
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 80
- 239000002105 nanoparticle Substances 0.000 title claims description 46
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title description 27
- 229910052725 zinc Inorganic materials 0.000 title description 26
- 239000011701 zinc Substances 0.000 title description 26
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 33
- -1 alkylene glycol Chemical compound 0.000 claims description 20
- 239000011787 zinc oxide Substances 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 12
- 229940124597 therapeutic agent Drugs 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 210000000214 mouth Anatomy 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 6
- VVOAZFWZEDHOOU-UHFFFAOYSA-N honokiol Natural products OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000000606 toothpaste Substances 0.000 claims description 6
- 239000000551 dentifrice Substances 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000013355 food flavoring agent Nutrition 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- 239000004075 cariostatic agent Substances 0.000 claims description 4
- 239000007910 chewable tablet Substances 0.000 claims description 4
- 235000015218 chewing gum Nutrition 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 4
- 239000002324 mouth wash Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 229960003500 triclosan Drugs 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 229940034610 toothpaste Drugs 0.000 claims description 3
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 claims description 2
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 claims description 2
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 claims description 2
- 230000007505 plaque formation Effects 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 claims description 2
- 229940051866 mouthwash Drugs 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 239000011324 bead Substances 0.000 claims 1
- 229960004830 cetylpyridinium Drugs 0.000 claims 1
- 229940112822 chewing gum Drugs 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229940092969 oral strip Drugs 0.000 claims 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 7
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000002882 anti-plaque Effects 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000010455 vermiculite Substances 0.000 description 4
- 235000019354 vermiculite Nutrition 0.000 description 4
- 229910052902 vermiculite Inorganic materials 0.000 description 4
- 150000003751 zinc Chemical class 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 3
- 239000011746 zinc citrate Substances 0.000 description 3
- 235000006076 zinc citrate Nutrition 0.000 description 3
- 229940068475 zinc citrate Drugs 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- 229940006174 zinc valerate Drugs 0.000 description 2
- CHJMFFKHPHCQIJ-UHFFFAOYSA-L zinc;octanoate Chemical compound [Zn+2].CCCCCCCC([O-])=O.CCCCCCCC([O-])=O CHJMFFKHPHCQIJ-UHFFFAOYSA-L 0.000 description 2
- BUDAIZWUWHWZPQ-UHFFFAOYSA-L zinc;pentanoate Chemical compound [Zn+2].CCCCC([O-])=O.CCCCC([O-])=O BUDAIZWUWHWZPQ-UHFFFAOYSA-L 0.000 description 2
- PFNQVRZLDWYSCW-UHFFFAOYSA-N (fluoren-9-ylideneamino) n-naphthalen-1-ylcarbamate Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1=NOC(=O)NC1=CC=CC2=CC=CC=C12 PFNQVRZLDWYSCW-UHFFFAOYSA-N 0.000 description 1
- JLPAMKUIIFHLBH-UHFFFAOYSA-N 1,2-dihydroxypropane-1-sulfonic acid Chemical compound CC(O)C(O)S(O)(=O)=O JLPAMKUIIFHLBH-UHFFFAOYSA-N 0.000 description 1
- BMFMTNROJASFBW-UHFFFAOYSA-N 2-(furan-2-ylmethylsulfinyl)acetic acid Chemical compound OC(=O)CS(=O)CC1=CC=CO1 BMFMTNROJASFBW-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- JJKVMNNUINFIRK-UHFFFAOYSA-N 4-amino-n-(4-methoxyphenyl)benzamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=CC=C(N)C=C1 JJKVMNNUINFIRK-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- JRYPYBSTNIBOTD-UHFFFAOYSA-L C(C=1C(C(=O)[O-])=CC=CC1)(=O)OC(C)=O.[Zn+2].C(C)(=O)OC(C=1C(C(=O)[O-])=CC=CC1)=O Chemical compound C(C=1C(C(=O)[O-])=CC=CC1)(=O)OC(C)=O.[Zn+2].C(C)(=O)OC(C=1C(C(=O)[O-])=CC=CC1)=O JRYPYBSTNIBOTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 229930182843 D-Lactic acid Natural products 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- PSIOOHPZLJTGJH-UHFFFAOYSA-M S(=O)(=O)([O-])[O-].[NH4+].[Zn+] Chemical compound S(=O)(=O)([O-])[O-].[NH4+].[Zn+] PSIOOHPZLJTGJH-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- ONVGHWLOUOITNL-UHFFFAOYSA-N [Zn].[Bi] Chemical compound [Zn].[Bi] ONVGHWLOUOITNL-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- XKLVLDXNZDIDKQ-UHFFFAOYSA-N butylhydrazine Chemical compound CCCCNN XKLVLDXNZDIDKQ-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940022769 d- lactic acid Drugs 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- WSUTUEIGSOWBJO-UHFFFAOYSA-N dizinc oxygen(2-) Chemical compound [O-2].[O-2].[Zn+2].[Zn+2] WSUTUEIGSOWBJO-UHFFFAOYSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- MFGZXPGKKJMZIY-UHFFFAOYSA-N ethyl 5-amino-1-(4-sulfamoylphenyl)pyrazole-4-carboxylate Chemical compound NC1=C(C(=O)OCC)C=NN1C1=CC=C(S(N)(=O)=O)C=C1 MFGZXPGKKJMZIY-UHFFFAOYSA-N 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- REGPDRSDSZELCD-UHFFFAOYSA-N phenol;zinc Chemical compound [Zn].OC1=CC=CC=C1 REGPDRSDSZELCD-UHFFFAOYSA-N 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- WSFQLUVWDKCYSW-UHFFFAOYSA-M sodium;2-hydroxy-3-morpholin-4-ylpropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN1CCOCC1 WSFQLUVWDKCYSW-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- BIKXLKXABVUSMH-UHFFFAOYSA-N trizinc;diborate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]B([O-])[O-].[O-]B([O-])[O-] BIKXLKXABVUSMH-UHFFFAOYSA-N 0.000 description 1
- SOLUNJPVPZJLOM-UHFFFAOYSA-N trizinc;distiborate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-][Sb]([O-])([O-])=O.[O-][Sb]([O-])([O-])=O SOLUNJPVPZJLOM-UHFFFAOYSA-N 0.000 description 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 1
- LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical compound [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- GTQFPPIXGLYKCZ-UHFFFAOYSA-L zinc chlorate Chemical compound [Zn+2].[O-]Cl(=O)=O.[O-]Cl(=O)=O GTQFPPIXGLYKCZ-UHFFFAOYSA-L 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
- 229940007718 zinc hydroxide Drugs 0.000 description 1
- 229910021511 zinc hydroxide Inorganic materials 0.000 description 1
- 229940098697 zinc laurate Drugs 0.000 description 1
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 1
- OMSYGYSPFZQFFP-UHFFFAOYSA-J zinc pyrophosphate Chemical compound [Zn+2].[Zn+2].[O-]P([O-])(=O)OP([O-])([O-])=O OMSYGYSPFZQFFP-UHFFFAOYSA-J 0.000 description 1
- GAWWVVGZMLGEIW-GNNYBVKZSA-L zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 1
- 229940100530 zinc ricinoleate Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- VRGNUPCISFMPEM-ZVGUSBNCSA-L zinc;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Zn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VRGNUPCISFMPEM-ZVGUSBNCSA-L 0.000 description 1
- LPEBYPDZMWMCLZ-CVBJKYQLSA-L zinc;(z)-octadec-9-enoate Chemical compound [Zn+2].CCCCCCCC\C=C/CCCCCCCC([O-])=O.CCCCCCCC\C=C/CCCCCCCC([O-])=O LPEBYPDZMWMCLZ-CVBJKYQLSA-L 0.000 description 1
- MXODCLTZTIFYDV-UHFFFAOYSA-L zinc;1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylate Chemical compound [Zn+2].C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C([O-])=O.C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C([O-])=O MXODCLTZTIFYDV-UHFFFAOYSA-L 0.000 description 1
- FRZSCIVUSFMNBX-UHFFFAOYSA-L zinc;12-hydroxyoctadecanoate Chemical compound [Zn+2].CCCCCCC(O)CCCCCCCCCCC([O-])=O.CCCCCCC(O)CCCCCCCCCCC([O-])=O FRZSCIVUSFMNBX-UHFFFAOYSA-L 0.000 description 1
- XLMCDAMBOROREP-UHFFFAOYSA-N zinc;3-phosphonooxypropane-1,2-diolate Chemical compound [Zn+2].OP(O)(=O)OCC([O-])C[O-] XLMCDAMBOROREP-UHFFFAOYSA-N 0.000 description 1
- KVSXXOUZYJZCPY-UHFFFAOYSA-L zinc;4-cyclohexylbutanoate Chemical compound [Zn+2].[O-]C(=O)CCCC1CCCCC1.[O-]C(=O)CCCC1CCCCC1 KVSXXOUZYJZCPY-UHFFFAOYSA-L 0.000 description 1
- NEYNBSGIXOOZGZ-UHFFFAOYSA-L zinc;butoxymethanedithioate Chemical compound [Zn+2].CCCCOC([S-])=S.CCCCOC([S-])=S NEYNBSGIXOOZGZ-UHFFFAOYSA-L 0.000 description 1
- JDLYKQWJXAQNNS-UHFFFAOYSA-L zinc;dibenzoate Chemical compound [Zn+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 JDLYKQWJXAQNNS-UHFFFAOYSA-L 0.000 description 1
- NDKWCCLKSWNDBG-UHFFFAOYSA-N zinc;dioxido(dioxo)chromium Chemical compound [Zn+2].[O-][Cr]([O-])(=O)=O NDKWCCLKSWNDBG-UHFFFAOYSA-N 0.000 description 1
- XAEWLETZEZXLHR-UHFFFAOYSA-N zinc;dioxido(dioxo)molybdenum Chemical compound [Zn+2].[O-][Mo]([O-])(=O)=O XAEWLETZEZXLHR-UHFFFAOYSA-N 0.000 description 1
- XKMZOFXGLBYJLS-UHFFFAOYSA-L zinc;prop-2-enoate Chemical compound [Zn+2].[O-]C(=O)C=C.[O-]C(=O)C=C XKMZOFXGLBYJLS-UHFFFAOYSA-L 0.000 description 1
- XDWXRAYGALQIFG-UHFFFAOYSA-L zinc;propanoate Chemical compound [Zn+2].CCC([O-])=O.CCC([O-])=O XDWXRAYGALQIFG-UHFFFAOYSA-L 0.000 description 1
- WNZNEKPFXJXMSK-UHFFFAOYSA-L zinc;quinoline-2-carboxylate Chemical compound [Zn+2].C1=CC=CC2=NC(C(=O)[O-])=CC=C21.C1=CC=CC2=NC(C(=O)[O-])=CC=C21 WNZNEKPFXJXMSK-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Description
本發明係說明包括媒劑及實質上非聚集奈米顆粒型式之鋅離子來源的口腔組成物及使用此等組成物的方法。該組成物提供抗噬菌斑及抗惡臭而利於使用者且內含奈米顆粒可容許存在於組成物中之鋅離子數量降低而維持功效。
[0001]口部醫護調配物中之鋅離子提供使用者許多有利的效益。例如,鋅離子已知具有抗噬菌斑、抗結石、及防臭的特性。然而,鋅伴隨著許多負面的感官特性:例如,澀味及令人不悅逗留不去的味道。由於具有負面感官特性之產物不被消費者所接受之實際事件,此等特性限制鋅離子-提供的化合物使用於口部醫護產物中。再者,某些鋅鹽例如氧化鋅具有低的水溶性且彼等鋅鹽於操作環境中之活性典型的比其他鋅型式低。此為鋅來源使用於口部醫護產物中之另一限制。
[0002]包括聚集鋅氧化鋅顆粒及足夠量液態媒劑以提供想要的稠性之潔牙劑係已知於此方面技藝中。然而,能於操作環境下使用少量鋅離子而不會影響鋅離子活性之含有實質上非聚集鋅奈米顆粒的口腔化合物尚未報導。應想要提供含有低含量鋅離子來源但具有相同或較佳有利效應之鋅離子以及味道問題解決的口腔組成物。
[0003]本發明提供了包括媒劑及實質上非聚集奈米顆粒型式之鋅離子來源的口腔組成物。非聚集鋅奈米顆粒可以低於約1重量%之量存在且奈米顆粒之尺寸可為大約1至大約250微米。
[0004]含有鋅奈米顆粒之口腔組成物進一步包括一種或多種治療劑,例如,抗齲齒劑及抗細菌劑,例如三氯生,氟離子,或亞錫離子。
[0005]另一具體例中,本發明提供了包括實質上非聚集奈米顆粒型式之鋅離子來源的薄膜。非聚集鋅奈米顆粒可以低於大約1重量%之量存在且奈米顆粒之尺寸可為大約1至大約250微米。
[0006]本發明又提供了維持或提昇人類或動物全身健康的方法。該方法包括將含有實質上非聚集奈米顆粒型式之鋅離子來源的組成物給藥至口腔的步驟。
[0008]本發明係關於口腔組成物,其可用於預防或減低噬菌斑形成;牙齦炎、牙周炎、及/或口腔組織發炎發展;口臭;及/或全身性發炎連鎖反應起動。更特別的是,本發明係關於包含實質上非聚集奈米顆粒型式之鋅離子來源的口腔潔牙組成物。
[0009]本發明係從不僅提供許多有益於口部及/或全身,而且容許調配者降低調配物中鋅離子來源之使用量,以保持想要功效程度之非聚集奈米顆粒大小之鋅離子來源的口腔組成物中發現而產生。該減低係用來改善伴隨著習用含鋅離子組成物之負面感官特性,以及增強配方透明度。
[0010]本文中所指之〝口腔組成物〞係為任何適合給藥或施用於人類或動物患者上以增進患者之健康、衛生或外表,包括預防或治療任何生理障礙之組成物。
[0011]本發明之組成物係包含鋅奈米顆粒。顆粒宜具有在毫微-範圍內之尺寸,亦即,大約1至大約1000毫微米。奈米顆粒宜具有大約1毫微米至大約850毫微米,大約50毫微米至大約150毫微米,大約15毫微米至大約500毫微米,大約30毫微米至大約250毫微米及/或大約5毫微米至大約100毫微米之平均顆粒大小(APS)。
[0012]使用於本發明組成物中之鋅奈米顆粒為非聚集者。非聚集之意為本發明之奈米顆粒並非集結堆入具有尺寸大於約1微米,較佳係大於約950毫微米或850毫微米之團塊(cluster)中。今發現非聚集鋅奈米顆粒在某些大於或類似於聚集鋅離子來源者之情況下顯示抗噬菌斑效益。圖1顯示含有(i)非聚集氧化鋅奈米顆粒,(ii)聚集氧化鋅及(iii)檸檬酸鋅之組成物於試管內效益的比較。
[0013]然而,鋅奈米顆粒可用聚集奈米顆粒及/或具有APS大於1微米之鋅離子來源,如果想要,予以混合。較佳者為,併入調配物中之奈米顆粒超過80%係非聚集者。更佳者為,超過90%之奈米顆粒係非聚集者。
[0014]組成物可含有任何數量之非聚集鋅奈米顆粒。然而,與習用口腔調配物中所使用之數量相比較時,使用根據本發明之鋅離子來源可降低而提供實質上功效不減之鋅離子。較佳者為,口腔組成物包含低於約1重量%之鋅離子來源,以大約0.3重量%至大約0.7重量%及0.5重量%至大約0.9重量%之量為更佳。
[0015]用於本發明組成物之鋅離子來源可為此方面技藝中任何已知或經發展之來源或此等來源之任何組合物或混合物。例如,任何鋅鹽及/或化合物可用作為鋅離子來源且此等鋅離子來源包括水溶性或不溶性、有機及無機的鋅鹽。可使用之適當鋅化合物之例,包括但不侷限於,醋酸鋅、乙醯基乙醯酸鋅、硫酸鋅銨、苯甲酸鋅、溴化鋅、正矽酸鋅鈹、硼酸鋅、丁基酞酸鋅、丁基黃原酸鋅、辛酸鋅、碳酸鋅、氯胺酸鋅、氯酸鋅、鉻酸鋅、環己烷丁酸鋅、氯化鋅、棓酸鋅、氟化鋅、α-葡庚糖酸鋅、葡糖酸鋅、甘油醯磷酸鋅、氫氧化鋅、8-羥基喹啉鋅、12-羥基硬脂酸鋅、碘化鋅、丙烯酸鋅、氧化鋅、丙酸鋅、異戊酸鋅、D-乳酸鋅、DL-乳酸鋅月桂酸鋅、六氟矽酸鋅、甲基丙烯酸鋅、鉬酸鋅、環烷酸鋅、辛酸鋅、油酸鋅、正磷酸鋅、酚磺酸鋅、吡啶-2-硫醇-1-氧化鋅、焦磷酸鋅、樹脂酸鋅、水楊酸鋅、硫酸鋅、硝酸鋅、硒化鋅、硬脂酸鋅、磺胺酸鋅、酒石酸鋅、碲酸鋅、鎢酸鋅、戊酸鋅、釩酸鋅、三溴水楊醯替苯胺鋅、及蓖麻油酸鋅。較佳者為,氧化鋅可用作為口腔組成物之鋅離子來源。
[0016]非聚集鋅奈米顆粒可於任何型式的組成物中提供。其可單純地併入例如,凝膠、流體、固態或糊膏組成物中,或者,其可例如以鋅離子奈米顆粒吸附至顆粒之型式,併入乳濁液、顆粒、膠體粒子、核-殼聚合物傳送裝置及/或薄膜組成物中而提供。此等傳送型式(forma)本身可併入例如,凝膠、流體、固態或糊膏組成物中或可同樣提供至口腔。
[0017]於一具體例中,非聚集鋅奈米顆粒係存在於薄膜中。薄膜可為任何想要的結構,只要其不會明顯妨礙鋅奈米顆粒的效益。薄膜可為,例如,單-層或多-層者。薄膜可以已知於此方面技藝中之薄膜形態,例如,聚合物,編織或非-編織的紡織品,或經壓製或製成薄片的物質之一種製得。薄膜可從包括羥基烷基甲基纖維素、澱粉及澱粉薄膜形成劑之基質或治療劑,例如抗細菌劑中形成。薄膜基質可進一步包括水、另外的薄膜形成劑、成形劑、表面活化劑、增香劑、甜味劑或染劑及乳化劑。
[0018]於一具體例中,薄膜係可藉著將羥基烷基甲基纖維素、澱粉組份、染劑、增香劑、甜味劑及/或治療劑及其他薄膜形成組份溶解於相溶性溶劑中以形成薄膜形成組成物而製備。將薄膜形成組成物澆鑄於可釋放之載體上且乾燥而形成一張薄膜。薄膜可於高溫下使用乾燥烘箱、乾燥終端、真空乾燥器、或任何其他不會負面影響薄膜之組成成份的適當乾燥設備進行乾燥。
[0019]薄膜可具有任何組成物,然而,用於製備本發明之薄膜的適當薄膜形成劑可為羥基烷基纖維素,例如,羥基丙基纖維素、羥基乙基丙基纖維素、羥基丁基甲基纖維素、羥基丙基甲基纖維素及羧基甲基纖維素。纖維素聚合物宜為低黏度羥基丙基甲基纖維素聚合物(HPMC)。當HPMC用作為薄膜形成劑劑時,較佳的HPMC具有在大約1至大約200毫帕秒(mPa.s)範圍內之黏度,其係以2重量% HPMC水溶液於20℃使用烏別洛特黏度計測定。HPMC宜具有於20℃下大約3至大約75 mPa.s之黏度。
[0020]含有非聚集鋅奈米顆粒之薄膜可經加工處理至各種已知類型之市售產品例如,牙膏、膜片(film flake)、條片及貼布中。其次,可將薄膜本身併入其他口腔醫護產物,例如,漱口水、牙膏、液態增白劑、口香糖、小球體、嚼片、及錠片中。口腔醫護產物中之薄膜亦可用於裝飾性目的以及用於口腔醫護目標上。可將薄膜形成裝飾的形狀例如,心型、星型、菱型、方型及圓型。
[0021]一具體例中,具有非聚集鋅奈米顆粒之口腔組成物可藉著將組成物給藥至口腔而用於維持或提昇人類或動物之全身健康的方法中。典型地,該方法包含將有效量之口腔組成物給藥至人類或動物患者之口腔的步驟,藉以維持口腔醫護或口腔衛生,或改善口部外表。可將使用於該方法中之口腔組成物進一步加工處理成不同類型之最終產物以符合消費者的需求。例如,給藥至人類或動物之組成物可為選自於漱口水、牙膏、液態增白劑、口香糖、小球體、嚼片、及錠片之型式。
根據一具體例,具有鋅奈米顆粒之口腔組成物可進一步含有一種或多種治療劑以改善或增強組成物之口腔衛生效益。習用於口腔醫護產物中之已知或用作為治療劑的物質可用於本發明之口腔組成物中。典型地,治療劑係選自於抗齲齒劑或抗細菌劑。治療劑之實例可包括三氯生、亞錫離子,抗-發炎劑、抗-氧化劑、抗-敏感劑、增白劑、氟離子、厚朴酚(honokiol)、木蘭酚(magnolol)、精胺酸酯(arginate ester)、十六烷基鈚錠鹽、及精胺酸鹽,例如,乙基月桂醯基精胺酸氫氯化物(ELAH)。
治療劑係以大約0.1重量%至大約5重量%,較佳為大約0.2重量%至大約1重量%之量存在。
根據本發明之口腔組成物的製備中係使用口部可接受的媒劑。任何已知或將要發展於此方面技藝中者皆可包括。媒劑可包括含有濕潤劑較佳為甘油或山梨糖醇或伸烷基二醇,例如聚乙二醇或丙二醇之水相,其中,水係以潔牙劑之大約5重量%至大約80重量%及甘油,山梨糖醇及/或伸烷基二醇組份共計約5重量%至約80重量%,更典型的為大約30%至大約45重量%之量存在。
口腔組成物可進一步含有以大約1重量%至大約10重量%,較佳為大約1重量%至大約3重量%比例之無機或天然或合成的增稠劑或膠化劑。本發明操作中所使用之適當增稠劑或膠化劑包括無機性增稠矽石,例如,愛爾蘭青苔、iota-角叉菜、西黃蓍膠、聚乙烯基吡咯烷酮、及非晶形矽石,其可得自於美國紐澤西州愛迪生市胡柏公司商標名下之ZEODENT165。
[0026]擦亮劑例如,矽石、煅燒礬土、碳酸氫鈉、碳酸鈣、磷酸二鈣及焦磷酸鈣可包含於本發明所使用之口腔組成物中。目視-清晰的潔牙組成物可藉著使用擦亮劑,例如膠質二氧化矽,例如彼等可得自於美國紐澤西州愛迪生市胡柏公司以ZEODENT115商標名稱販售者,或鹼金屬鋁矽酸鹽絡合物(那就是,含礬土的矽石合併於其基質中)而獲得。此等擦亮劑想要具有接近潔牙組成物中所用之膠化劑-液體(包括水及/或濕潤劑)系統之折光指數的折光指數。擦亮劑通常係以大約10重量%至大約50重量%之重量濃度存在於口腔組成物中。
[0027]表面活化劑係使用於本發明之口腔組成物中以達到增加預防性作用且使即溶組成物成為更能裝飾性地接受。適當表面活化劑之例包括高級脂肪酸一甘油酯一硫酸酯之水溶性鹽類,例如,經氫化之椰子油脂肪酸之一硫酸鹽化的一甘油酯的鈉鹽,椰基醯胺基丙基甜菜鹼,高級烷基硫酸鹽,例如月桂基硫酸鈉,烷基芳基磺酸鹽例如十二烷基苯磺酸鈉,高級烷基磺酸基醋酸鈉,1,2-二羥基丙烷磺酸鹽之高級脂肪酸酯類,及低級脂族胺基羧酸化合物之實質上飽和的高級脂族醯基醯胺類,例如彼等於脂肪酸中含有12至16個碳、烷基或醯基基團等者。此等之例為N-月桂醯甲替甲氨酸,及N-月桂醯基、N-肉荳蔻醯基、或N-軟脂醯基甲替甲氨酸酯之鈉、鉀及乙醇胺鹽類。陰離子表面活化劑典型的係以大約1重量%至大約15重量%,較佳為大約5重量%至大約10重量%之量存在於本發明之口腔組成物中。
[0028]任何其他已知或經發展使用於口腔組成物中之添加劑可併入組成物中,包括抗-齲齒劑、增香劑、染劑、其他活性劑、增白化合物、抗-酸性化合物、抗-敏感性化合物、維生素、藥草及其他植物性藥品、抗-發炎劑、抗-氧化劑化合物、荷爾蒙、及其他蛋白質或胜肽。
[0029]將水、濕潤劑,例如,甘油、山梨糖醇聚乙二醇分散於習用的混合物中直到混合物變成均質的凝膠相以製備本發明之口腔組成物。將擦亮劑加入凝膠相中。將此等組份混合直到獲得均相。之後,將增稠劑、任何增香劑及表面活化劑組份加入且將組份以高速予以混合直到約20至100毫米汞柱真空。
[0030]本發明進一步以下列實例闡明,但非侷限於此。下列實例之變化例在不背離本發明範圍之內係可能的。
[0031]含有各種氧化鋅奈米顆粒含量之口腔組成物係藉著使用列舉於下列表1中之成份而製備。每個組成物具有相同量之相同成份,但氧化鋅奈米顆粒之含量係在由0%至2%之範圍。
[0032]於每個實例中,將組份予以混合直到形成均質的混合物。將實例1-5之口腔組成物進行試驗以評估各個之抗噬菌斑活性。口腔組成物之抗噬菌斑活性試管內試驗顯示於下列表II中。
[0033]應澆鑄於薄膜中之生料調配物係使用顯示於表III中之一般薄膜-形成成份製備。
於澆鑄且乾燥之後,將產生的薄膜切成1毫米乘1毫米大小之適當方塊,且併入標準凝膠調配物牙膏中。
[0034]雖然本發明業已於特定實例中以參考說明,一般精於此方面技藝之人士應顯而易知可在其範圍之內逕行各種變化。
圖1為顯示聚集氧化鋅、檸檬酸鋅、及非聚集氧化鋅顆粒對試管內噬菌斑生長之效應的條線圖表。
Claims (17)
- 一種口腔組成物,其係包含一媒劑、薄膜形成劑及呈非聚集奈米顆粒型式的氧化鋅,該奈米顆粒具有平均顆粒大小1毫微米至850毫微米,其中該氧化鋅係以口腔組成物之0.3至1重量%的量存在,該媒劑包含伸烷基二醇,且該薄膜形成劑包含羥烷基纖維素或澱粉。
- 如申請專利範圍第1項之口腔組成物,其中,超過90%之奈米顆粒係非聚集者。
- 如申請專利範圍第1項之口腔組成物,其中,超過80%之奈米顆粒係非聚集者。
- 如申請專利範圍第1項之口腔組成物,其中,奈米顆粒之尺寸為1至250毫微米。
- 如申請專利範圍第1項之口腔組成物,其中,口腔組成物進一步包含一種或多種治療劑。
- 如申請專利範圍第5項之口腔組成物,其中,治療劑係選自於抗齲齒劑及抗細菌劑。
- 如申請專利範圍第6項之口腔組成物,其中,治療劑係選自於下列組成之群組:三氯生(triclosan)、亞錫離子、氟、精胺酸鹽,及十六烷基鈚錠鹽、厚朴酚(Honokiol)及木蘭酚(magnolol)。
- 如申請專利範圍第1項之口腔組成物,其中,口腔組成物進一步包含選自於下列組成之群組:磨擦劑、表面活化劑、增香劑、及甜味劑之組份。
- 一種薄膜,其包含薄膜形成劑及呈非聚集奈米顆粒型式的氧化鋅,該奈米顆粒具有平均顆粒大小1毫微米至850毫微米,其中該氧化鋅係以基於該薄膜重量之17至25重量%的量存在,且該薄膜形成劑包含羥烷基纖維素或澱粉。
- 如申請專利範圍第9項之薄膜,其中該奈米顆粒之尺寸為1至250毫微米。
- 如申請專利範圍第10項之薄膜,其中該薄膜進一步包含一種或多種治療劑。
- 一種潔牙劑,其包含如申請專利範圍第9項之薄膜。
- 一種口腔醫護物品,其包含如申請專利範圍第1項之口腔組成物,該物品包含一口腔上可接受之媒劑及0.3至1重量%之非聚集的氧化鋅奈米顆粒,該奈米顆粒具有平均顆粒大小1毫微米至850毫微米,其中該口腔醫護物品係選自於下列組成之群組:漱口水、口條片(oral strip)、牙膏、液態增白劑、口香糖、小球體(bead)、嚼片、錠片及噴霧劑。
- 如申請專利範圍第13項之口腔醫護物品,其中,奈米顆粒之尺寸為1至250毫微米。
- 一種如申請專利範圍第1項之組成物用於製造供預防或減少人類或動物中噬菌斑形成的口腔醫護產品之用途。
- 如申請專利範圍第15項之用途,其中,該組成物係為選自於下列組成群組:漱口水、口條片、牙膏、液 態增白劑、口香糖、小球體、嚼片、錠片及噴霧劑之型式。
- 一種口腔組成物,其包含一媒劑、薄膜形成劑、呈非聚集奈米顆粒型式的氧化鋅、及三氯生,其中該奈米顆粒具有平均顆粒大小1毫微米至850毫微米,且其中該氧化鋅係以口腔組成物之0.3至1重量%的量存在,該媒劑包含伸烷基二醇,且該薄膜形成劑包含羥烷基纖維素或澱粉。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/186,510 US9242125B2 (en) | 2005-07-21 | 2005-07-21 | Oral composition containing non-aggregated zinc nanoparticles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200744653A TW200744653A (en) | 2007-12-16 |
| TWI430814B true TWI430814B (zh) | 2014-03-21 |
Family
ID=37421126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095126460A TWI430814B (zh) | 2005-07-21 | 2006-07-20 | 含有非聚集鋅奈米顆粒之口腔組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9242125B2 (zh) |
| EP (1) | EP1904025B1 (zh) |
| JP (2) | JP2009502799A (zh) |
| CN (1) | CN101227883B (zh) |
| AR (1) | AR057475A1 (zh) |
| AU (1) | AU2006272930B2 (zh) |
| BR (1) | BRPI0613420B1 (zh) |
| CA (1) | CA2615601C (zh) |
| MX (1) | MX2008000934A (zh) |
| MY (1) | MY146240A (zh) |
| RU (1) | RU2394554C2 (zh) |
| TW (1) | TWI430814B (zh) |
| WO (1) | WO2007013937A1 (zh) |
| ZA (1) | ZA200801003B (zh) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060045914A1 (en) * | 2004-08-26 | 2006-03-02 | Isp Investments Inc. | Matrix composition for stable microemulsions |
| US8273381B1 (en) | 2006-04-14 | 2012-09-25 | Auburn University | Compositions for and methods of controlling olfactory responses to odorants |
| US20100239629A1 (en) * | 2006-07-31 | 2010-09-23 | Isp Investments Inc. | Delivery system for delivering bioactive materials |
| US20100260691A1 (en) * | 2006-07-31 | 2010-10-14 | Narayanan Kolazi S | Aqueous compositions containing a hydrophobic material |
| US8747871B2 (en) * | 2006-09-28 | 2014-06-10 | Isp Investments Inc. | Synergistic matrix composite for making stable microemulsions of active ingredients |
| GB0706787D0 (en) * | 2007-04-05 | 2007-05-16 | Glaxo Group Ltd | Novel use |
| CA2710583C (en) | 2008-02-08 | 2015-10-06 | Colgate-Palmolive Company | Compositions and devices |
| US20090202456A1 (en) * | 2008-02-08 | 2009-08-13 | Colgate-Palmolive Company | Novel salts and their uses |
| CN101292943B (zh) * | 2008-06-20 | 2010-04-14 | 陕西太和科技股份有限公司 | 纳米氧化锌牙膏 |
| TWI404544B (zh) | 2008-08-11 | 2013-08-11 | Colgate Palmolive Co | 含珠粒之口腔保健組成物 |
| CA2689190A1 (en) | 2008-12-29 | 2010-06-29 | Alistair John Mclennan | Vinyl acetate/ vinyl 2-ethylhexanoate co-polymer binder resins |
| TWI442937B (zh) * | 2009-05-26 | 2014-07-01 | Colgate Palmolive Co | 較高含量的含鋅薄膜 |
| EP2435013B1 (en) * | 2009-05-26 | 2019-07-24 | Colgate-Palmolive Company | Dentifrice composition |
| TWI396554B (zh) * | 2009-05-26 | 2013-05-21 | Colgate Palmolive Co | 增進可溶性鋅的量之口腔保健調配物 |
| US9408798B2 (en) | 2009-12-04 | 2016-08-09 | Colgate-Palmolive Company | Dissolvable films containing high concentrations of nonionic surfactants such as polysorbates to enhance high solid loadings |
| TWI458497B (zh) * | 2010-01-13 | 2014-11-01 | Colgate Palmolive Co | 口腔組成物中氧化鋅薄膜之安定化 |
| US20110236444A1 (en) * | 2010-03-25 | 2011-09-29 | Darsillo Michael S | Antimicrobial Silica Composites |
| JP5769795B2 (ja) | 2010-03-31 | 2015-08-26 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | 口腔ケア組成物 |
| JP5694506B2 (ja) * | 2010-03-31 | 2015-04-01 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | 口腔ケア組成物 |
| AU2010358063B2 (en) * | 2010-07-29 | 2013-10-17 | Colgate-Palmolive Company | Phosphate free oral care compositions based on Magnolia antibacterial agent |
| MY162656A (en) | 2010-11-08 | 2017-06-30 | Colgate Palmolive Co | Oral compositions containing microaggregates |
| WO2012078134A1 (en) * | 2010-12-07 | 2012-06-14 | Colgate-Palmolive Company | Oral and personal care compositions comprising zinc containing films |
| RU2619867C2 (ru) | 2011-12-16 | 2017-05-18 | Колгейт-Палмолив Компани | Многофазные композиции для ухода за полостью рта |
| CA2858042C (en) | 2011-12-16 | 2019-01-29 | Colgate-Palmolive Company | Color changing compositions |
| CN104135990B (zh) | 2011-12-16 | 2019-06-18 | 高露洁-棕榄公司 | 包含膜的组合物 |
| CN102919495B (zh) * | 2012-10-23 | 2013-11-20 | 河南科技大学 | 一种具有除口臭功能的口香糖 |
| US9498418B2 (en) | 2012-12-14 | 2016-11-22 | Colgate-Palmolive Company | Abradable films for use in oral care |
| JP5976955B2 (ja) * | 2012-12-19 | 2016-08-24 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | 酸化亜鉛およびトリメチルグリシンを含むオーラルケア製品 |
| MX370456B (es) | 2013-12-23 | 2019-12-13 | Colgate Palmolive Co | Composiciones que contienen película para uso oral. |
| WO2015157241A1 (en) * | 2014-04-10 | 2015-10-15 | Basf Se | Oral care compositions |
| SG10201408339WA (en) | 2014-12-12 | 2016-07-28 | Hock Cheong Automec Pte Ltd | A cleaning system and a method of cleaning a subject |
| US9625449B2 (en) | 2014-12-23 | 2017-04-18 | Colgate-Palmolive Company | Determining the bioavailability of zinc (II) ions |
| US9435745B2 (en) | 2014-12-23 | 2016-09-06 | Colgate-Palmolive Company | Measuring the rate of release of metal ions |
| US9354219B1 (en) | 2014-12-23 | 2016-05-31 | Colgate-Palmolive Company | Detecting stannous ions |
| RU2017128410A (ru) * | 2015-07-01 | 2019-02-12 | Колгейт-Палмолив Компани | Композиции для ухода за полостью рта и способы их применения |
| RU2615370C2 (ru) * | 2015-07-23 | 2017-04-04 | Колгейт-Палмолив Компани | Композиции для полости рта, содержащие микроагрегаты |
| US10485746B2 (en) * | 2015-09-11 | 2019-11-26 | W.M. Wrigley Jr. Company | Synergistic antibacterial effects of magnolia bark extract and L-arginine, Nα-lauroyl ethyl ester on salivary bacteria |
| RU2595875C1 (ru) * | 2015-09-17 | 2016-08-27 | Игорь Иванович Зоткин | Применение соли цинка или меди (ii) в качестве компонента состава для ухода за полостью рта и состав для ухода за полостью рта |
| CA3024125A1 (en) | 2016-08-11 | 2018-02-15 | Colgate-Palmolive Company | Dentifrice including zinc and blue dye or pigment |
| US9974724B1 (en) | 2016-10-27 | 2018-05-22 | Colgate-Palmolive Company | Oral care compositions with increased whitening efficacy |
| WO2018080499A1 (en) * | 2016-10-27 | 2018-05-03 | Colgate-Palmolive Company | Oral care compositions with increased whitening efficacy |
| US20200246233A1 (en) * | 2019-02-01 | 2020-08-06 | Belle-Aire Fragrances, Inc. | Oral care product |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3946108A (en) * | 1971-11-26 | 1976-03-23 | Colgate-Palmolive Company | Dentifrice |
| US4138477A (en) | 1976-05-28 | 1979-02-06 | Colgate Palmolive Company | Composition to control mouth odor |
| US4568540A (en) | 1984-04-18 | 1986-02-04 | Johnson & Johnson | Oral hygiene compositions |
| US4863722A (en) | 1987-01-28 | 1989-09-05 | Jeffrey Martin, Inc. | Dentifrice compositions |
| FR2632185B1 (fr) | 1988-06-01 | 1992-05-22 | Rhone Poulenc Chimie | Silice pour compositions dentifrices compatible notamment avec le zinc |
| US5000944A (en) | 1989-06-09 | 1991-03-19 | Colgate-Palmolive Company | Zinc-containing oral products with reduced astringency |
| GB8922434D0 (en) | 1989-10-05 | 1989-11-22 | Unilever Plc | Oral compositions |
| US5503840A (en) * | 1991-08-09 | 1996-04-02 | E. I. Du Pont De Nemours And Company | Antimicrobial compositions, process for preparing the same and use |
| JP2964182B2 (ja) | 1991-09-10 | 1999-10-18 | 花王株式会社 | 象牙質知覚過敏治療剤 |
| GB9126306D0 (en) | 1991-12-11 | 1992-02-12 | Unilever Plc | Mouthwash compositions |
| US5374418A (en) * | 1992-02-13 | 1994-12-20 | Kao Corporation | Composition for use in oral cavity |
| AU6721494A (en) | 1993-05-13 | 1994-12-12 | Unilever Plc | Oral compositions containing triclosan for the treatment of aphthous ulcers |
| US5385727A (en) | 1993-05-19 | 1995-01-31 | Church & Dwight Co., Inc. | Dentifrices containing zinc oxide particles and sodium bicarbonate |
| US5330748A (en) | 1993-05-19 | 1994-07-19 | Church & Dwight Co., Inc. | Dentifrices containing zinc oxide particles |
| US5302373A (en) | 1993-06-10 | 1994-04-12 | Church & Dwight Co., Inc. | Liquid mouthwash containing a particulate bicarbonate suspension |
| ZA962939B (en) | 1995-04-12 | 1997-10-13 | Quest Int | Oral care compositions. |
| US5578295A (en) | 1995-04-28 | 1996-11-26 | The Procter & Gamble Company | Oral care compositions comprising certain substituted diphenyl ethers |
| JPH10236822A (ja) | 1997-02-27 | 1998-09-08 | Kao Corp | 酸化亜鉛微粒子及びその製造方法 |
| DK1054642T3 (da) | 1998-02-13 | 2008-09-08 | Britesmile Professional Llc | Lysaktiveret tandblegnings-sammensætning og fremgangsmåde til anvendelse af samme |
| JPH11246375A (ja) | 1998-02-27 | 1999-09-14 | Sunstar Inc | 口腔用組成物 |
| US6846478B1 (en) | 1998-02-27 | 2005-01-25 | The Procter & Gamble Company | Promoting whole body health |
| JP3719874B2 (ja) | 1998-04-24 | 2005-11-24 | サンスター株式会社 | 口腔用組成物 |
| GB9810806D0 (en) | 1998-05-21 | 1998-07-22 | Boots Co Plc | Odour absorbing agent |
| JP2000355515A (ja) | 1999-06-14 | 2000-12-26 | Kansai Koso Kk | 化粧料組成物 |
| IL147291A0 (en) * | 1999-07-02 | 2002-08-14 | Procter & Gamble | Compositions comprising orgosiloxane resins for delivering oral care substances |
| US6685920B2 (en) | 1999-11-12 | 2004-02-03 | The Procter & Gamble Company | Method of protecting teeth against erosion |
| US6537360B2 (en) * | 2000-01-31 | 2003-03-25 | Hanix Co., Ltd. | Tooth coating composition and over-coating composition therefor |
| JP2001278725A (ja) | 2000-03-31 | 2001-10-10 | Hanix:Kk | 歯牙被覆組成物およびその上塗組成物 |
| AU2000246679A1 (en) | 2000-04-27 | 2001-11-12 | The Procter And Gamble Company | Oral compositions comprising polyphenol herbal extracts |
| DE10028974A1 (de) | 2000-06-16 | 2002-01-03 | Henkel Kgaa | Thixotrope Mund- und Zahnpflegemittel |
| ATE321520T1 (de) * | 2000-09-26 | 2006-04-15 | Thomas R Patacca | Zusammensetzung zur zahnbeschichtung |
| US6723305B2 (en) | 2002-03-04 | 2004-04-20 | Colgate Palmolive Company | Anti-microbial breath freshening mouthrinse |
| US6984377B2 (en) * | 2002-05-29 | 2006-01-10 | J. M. Huber Corporation | Oral care products comprising calcium metasilicates |
| US6669929B1 (en) | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
| IN2012DN02781A (zh) | 2002-12-30 | 2015-09-18 | Colgate Palmolive Co | |
| US20080006083A1 (en) | 2006-06-26 | 2008-01-10 | Feinstein Adam J | Apparatus and method of transporting and loading probe devices of a metrology instrument |
-
2005
- 2005-07-21 US US11/186,510 patent/US9242125B2/en active Active
-
2006
- 2006-07-20 AR ARP060103136A patent/AR057475A1/es unknown
- 2006-07-20 TW TW095126460A patent/TWI430814B/zh not_active IP Right Cessation
- 2006-07-20 EP EP06787896.7A patent/EP1904025B1/en not_active Not-in-force
- 2006-07-20 RU RU2008106610/15A patent/RU2394554C2/ru not_active IP Right Cessation
- 2006-07-20 JP JP2008522940A patent/JP2009502799A/ja active Pending
- 2006-07-20 CA CA2615601A patent/CA2615601C/en not_active Expired - Fee Related
- 2006-07-20 AU AU2006272930A patent/AU2006272930B2/en not_active Ceased
- 2006-07-20 MY MYPI20063462A patent/MY146240A/en unknown
- 2006-07-20 MX MX2008000934A patent/MX2008000934A/es active IP Right Grant
- 2006-07-20 WO PCT/US2006/028090 patent/WO2007013937A1/en not_active Ceased
- 2006-07-20 BR BRPI0613420A patent/BRPI0613420B1/pt not_active IP Right Cessation
- 2006-07-20 CN CN200680026480.2A patent/CN101227883B/zh not_active Expired - Fee Related
-
2008
- 2008-01-30 ZA ZA200801003A patent/ZA200801003B/xx unknown
-
2012
- 2012-03-16 JP JP2012059938A patent/JP5595435B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| TW200744653A (en) | 2007-12-16 |
| EP1904025B1 (en) | 2016-10-19 |
| CN101227883B (zh) | 2015-01-28 |
| JP5595435B2 (ja) | 2014-09-24 |
| JP2012162536A (ja) | 2012-08-30 |
| BRPI0613420B1 (pt) | 2017-03-21 |
| BRPI0613420A2 (pt) | 2011-05-31 |
| EP1904025A1 (en) | 2008-04-02 |
| US9242125B2 (en) | 2016-01-26 |
| RU2394554C2 (ru) | 2010-07-20 |
| AR057475A1 (es) | 2007-12-05 |
| AU2006272930A1 (en) | 2007-02-01 |
| MY146240A (en) | 2012-07-31 |
| CN101227883A (zh) | 2008-07-23 |
| RU2008106610A (ru) | 2009-08-27 |
| JP2009502799A (ja) | 2009-01-29 |
| ZA200801003B (en) | 2009-05-27 |
| CA2615601A1 (en) | 2007-02-01 |
| US20070020201A1 (en) | 2007-01-25 |
| MX2008000934A (es) | 2008-03-27 |
| AU2006272930B2 (en) | 2010-06-03 |
| CA2615601C (en) | 2011-05-10 |
| WO2007013937A1 (en) | 2007-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI430814B (zh) | 含有非聚集鋅奈米顆粒之口腔組成物 | |
| CN104822360B (zh) | 表面活性剂体系用于含锌组合物 | |
| TWI442937B (zh) | 較高含量的含鋅薄膜 | |
| CN105530910B (zh) | 口腔护理组合物 | |
| TWI461217B (zh) | 口腔保健組成物 | |
| JP2015131835A (ja) | 悪臭制御のための口腔ケア配合物 | |
| TWI463995B (zh) | 含微聚集體之口腔用組成物 | |
| CN104023796A (zh) | 口腔护理组合物 | |
| US10426720B2 (en) | Film compositions for oral use | |
| TWI533888B (zh) | 口腔及個人保健組成物 | |
| JP2015157810A (ja) | 敏感なエナメル質のケアのための口腔ケア製品 | |
| CN113811366B (zh) | 口腔护理组合物 | |
| TW201340986A (zh) | 口腔保健組成物(二) | |
| TW201534337A (zh) | 含有薄膜之組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |